858143 | 18:1 Lyso PS
1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt)
18:1 Lyso PS
1-oleoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt)
CAS Registry Number is a Registered Trademark of the American Chemical Society
PS(18:1(9Z)/0:0)
18:1 LPS
C18:1 LPS
110726
Eum JY, Lee JC, Yi SS, Kim IY, Seong JK, Moon MH. Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2020 Jan 3:460849. doi: 10.1016/j.chroma.2020.460849. Epub ahead of print. PMID: 31928769.
PubMed ID: 31928769Shi Q, Jin S, Xiang X, Tian J, Huang R, Li S, Chen C, Xu H, Song C. The metabolic change in serum lysoglycerophospholipids intervened by triterpenoid saponins from Kuding tea on hyperlipidemic mice. Food Funct. 2019 Dec 11;10(12):7782-7792. doi: 10.1039/c9fo02142f.
PubMed ID: 31782452Tsugawa H, Satoh A, Uchino H, Cajka T, Arita M, Arita M. Mass Spectrometry Data Repository Enhances Novel Metabolite Discoveries with Advances in Computational Metabolomics. Metabolites. 2019 Jun 24;9(6). pii: E119. doi: 10.3390/metabo9060119.
PubMed ID: 31238512Yan Y, Du Z, Chen C, Li J, Xiong X, Zhang Y, Jiang H. Lysophospholipid profiles of apolipoprotein E-deficient mice reveal potential lipid biomarkers associated with atherosclerosis progression using validated UPLC-QTRAP-MS/MS-based lipidomics approach. J Pharm Biomed Anal. 2019 Jul 15;171:148-157. doi: 10.1016/j.jpba.2019.03.062. Epub 2019 Apr 5.
PubMed ID: 30999225D'Ambrosio JM, Albanèse V, Čopič A. Following Anterograde Transport of Phosphatidylserine in Yeast in Real Time. Methods Mol Biol. 2019;1949:35-46. doi: 10.1007/978-1-4939-9136-5_4.
PubMed ID: 30790247Feng Y, Chen B, Yu Q, Li L. Identification of Double Bond Position Isomers in Unsaturated Lipids by m-CPBA Epoxidation and Mass Spectrometry Fragmentation. Anal Chem. 2019 Jan 4. doi: 10.1021/acs.analchem.8b04905. [Epub ahead of print]
PubMed ID: 30608661Nishikawa, M., M. Kurano, H. Ikeda, J. Aoki, and Y. Yatomi. (2014). Lysophosphatidylserine has Bilateral Effects on Macrophages in the Pathogenesis of Atherosclerosis. J Atheroscler Thromb [PubMed]
PubMed ID: 25445889- Certificate of Analysis (Lot No. 858143C-10MG-A-037 and 5859CIA037)
- Certificate of Analysis (Lot No. 858143C-25MG-A-037 and 5859CJA037)
- Certificate of Analysis (Lot No. 858143C-5MG-A-037 and 5859CHA037)
- Certificate of Analysis (Lot No. 858143P-100MG-A-037 and 5859PLA037)
- Certificate of Analysis (Lot No. 858143P-10MG-A-037 and 5859PIA037)
- Certificate of Analysis (Lot No. 858143P-25MG-A-037 and 5859PJA037)
- Certificate of Analysis (Lot No. 858143P-50MG-A-037 and 5859PKA037)
- Certificate of Analysis (Lot No. 858143P-5MG-A-037 and 5859PHA037)
- Certificate of Analysis (Lot No. 858143P-100MG-B-037 and 5859PLB037)
- Certificate of Analysis (Lot No. 858143P-10MG-B-037 and 5859PIB037)
- Certificate of Analysis (Lot No. 858143P-25MG-B-037 and 5859PJB037)
- Certificate of Analysis (Lot No. 858143P-5MG-B-037 and 5859PHB037)
- Certificate of Analysis (Lot No. 858143C-5MG-B-037 and 5859CHB037)
- Certificate of Analysis (Lot No. 858143P-100MG-C-037 and 5859PLC037)
- Certificate of Analysis (Lot No. 858143P-5MG-C-037 and 5859PHC037)
- Certificate of Analysis (Lot No. 858143P-25MG-C-037 and 5859PJC037)
- Certificate of Analysis (Lot No. 858143C-10MG-B-037 and 5859CIB037)
- Certificate of Analysis (Lot No. 858143P-10MG-C-037 and 5859PIC037)
- Certificate of Analysis (Lot No. 858143P-5MG-D-037 and 5859PHD037)
- Certificate of Analysis (Lot No. 858143C-25MG-B-037 and 5859CJB037)
- Certificate of Analysis (Lot No. 858143P-5MG-E-037 and 5859PHE037)
- Certificate of Analysis (Lot No. 858143C-5MG-C-037 and 5859CHC037)
- Certificate of Analysis (Lot No. 858143P-5MG-F-037 and 5859PHF037)
- Certificate of Analysis (Lot No. 858143P-25MG-E-037 and 5859PJE037)
- Certificate of Analysis (Lot No. 858143P-25MG-D-037 and 5859PJCD037)
- Certificate of Analysis (Lot No. 858143C-5MG-D-037 and 5859CHD037)
- Certificate of Analysis (Lot No. 858143P-10MG-D-037 and 5859PID037)
- Certificate of Analysis (Lot No. 858143P-25MG-F-037 and 5859PJF037)
- Certificate of Analysis (Lot No. 858143P-10MG-A-040 and 5859PIA040)
- Certificate of Analysis (Lot No. 858143P-5MG-A-040 and 5859PHA040)
- Certificate of Analysis (Lot No. 858143P-5MG-B-040 and 5859PHB040)
- Certificate of Analysis (Lot No. 858143P-25MG-A-040 and 5859PJA040)
- Certificate of Analysis (Lot No. 858143P-5MG-C-040 and 5859PHC040)
- Certificate of Analysis (Lot No. 858143C-5MG-A-040 and 5859CHA040)
- Certificate of Analysis (Lot No. 858143P-5MG-E-040 and 5859PHE040)
- Certificate of Analysis (Lot No. 858143P-100MG-B-040 and 5859PLB040)
- Certificate of Analysis (Lot No. 858143P-25MG-A-041 and 5859PJA041)
- Certificate of Analysis (Lot No. 858143P-10MG-A-041 and 5859PIA041)
- Certificate of Analysis (Lot No. 858143P-5MG-A-041 and 5859PHA041)
- Certificate of Analysis (Lot No. 858143P-50MG-A-040 and 5859PKA040)
- Certificate of Analysis (Lot No. 858143P-25MG-B-041 and 5859PJB041)
- Certificate of Analysis (Lot No. 858143P-25MG-C-041 and 5859PJC041)
- Certificate of Analysis (Lot No. 858143C-10MG-A-041 and 5859CIA041)
- Certificate of Analysis (Lot No. 858143P-10MG-B-041 and 5859PIB041)
- Certificate of Analysis (Lot No. 858143P-10MG-C-041 and 5859PIC041)
- Certificate of Analysis (Lot No. 858143C-10MG-B-041 and 5859CIB041)
- Certificate of Analysis (Lot No. 858143C-5MG-A-041 and 5859CHA041)
- Certificate of Analysis (Lot No. 858143P-5MG-B-041 and 5859PHB041)
- Certificate of Analysis (Lot No. 858143P-100MG-B-041 and 5859PLB041)